Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMP “Pharmaceutical Inspectorate” Being Considered By FDA

Executive Summary

FDA is considering creating a dedicated force of inspectors to focus on pharmaceutical manufacturing in an effort to improve the expertise and uniformity of inspections

You may also be interested in...



Therapeutic Biologic GMP Inspections To Become “More Systems-Based”

Therapeutic biologics manufacturing compliance inspections will move toward the systems-based approach used by the Center for Drug Evaluation & Research, Office of Regulatory Affairs Regional Operations Director Deborah Ralston said

Therapeutic Biologic GMP Inspections To Become “More Systems-Based”

Therapeutic biologics manufacturing compliance inspections will move toward the systems-based approach used by the Center for Drug Evaluation & Research, Office of Regulatory Affairs Regional Operations Director Deborah Ralston said

Preapproval Inspections: Industry Urges FDA Transition To “For Cause”

FDA should consider moving to "for cause" preapproval inspections as part of its quality systems initiative, drug manufacturers told FDA at the Product Quality Research Institute/FDA conference in Washington, D.C. April 24

Related Content

UsernamePublicRestriction

Register

OM013164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel